Nicotinamide Riboside Preserves Ovarian Injury in Experimental Sepsis Model in Rats

Nicotinamide Riboside Preserves Ovarian Injury in Experimental Sepsis Model in Rats

Bibliographic Details
Main Authors:	Jale Selli, Dilek Vural Keles, Osman Nuri Keles, Muhammet Celik, Zeliha Yetim
Format:	Article
Language:	English
Published:	AVES 2023-06-01
Series:	Eurasian Journal of Medicine
Online Access:	https://www.eajm.org/en/nicotinamide-riboside-preserves-ovarian-injury-in-experimental-sepsis-model-in-rats-133454

Similar Items

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD<sup>+</sup> by Generating Dihydronicotinamide Riboside
by: Eleonora Ciarlo, et al.
Published: (2022-07-01)

Nicotinamide Riboside and Phycocyanin Oligopeptides Affect Stress Susceptibility in Chronic Corticosterone-Exposed Rats
by: Cemal Orhan, et al.
Published: (2023-10-01)

Emerging Role of Nicotinamide Riboside in Health and Diseases
by: Chiranjeev Sharma, et al.
Published: (2022-09-01)

Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells
by: Andrey Kropotov, et al.
Published: (2021-01-01)

Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
by: Mario Mehmel, et al.
Published: (2020-05-01)

New Crystalline Salts of Nicotinamide Riboside as Food Additives
by: Günter Schabert, et al.
Published: (2021-05-01)

Synthesis, Stability, and Bioavailability of Nicotinamide Riboside Trioleate Chloride
by: Amin Zarei, et al.
Published: (2021-12-01)

Nicotinamide, Nicotinamide Riboside and Nicotinic Acid—Emerging Roles in Replicative and Chronological Aging in Yeast
by: Ivan Orlandi, et al.
Published: (2020-04-01)

Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects
by: Ekaterina Podyacheva, et al.
Published: (2021-09-01)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
by: Lars Jansen Sverkeli, et al.
Published: (2021-07-01)

Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease
by: Johannes J. Gaare, et al.
Published: (2023-03-01)

Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice
by: Patrick M. Schaefer, et al.
Published: (2022-10-01)

Protective effect of daidzein on ovarian ischemia‑reperfusion injury in rats
by: Erdem Toktay, et al.
Published: (2022-03-01)

Comparison of protective effects of nicotinamide mononucleotide and nicotinamide riboside on DNA damage induced by cisplatin in HeLa cells
by: Shuting Qiu, et al.
Published: (2024-03-01)

Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
by: Nahid A Khan, et al.
Published: (2014-06-01)

Nicotinamide Riboside Regulates Chemotaxis to Decrease Inflammation and Ameliorate Functional Recovery Following Spinal Cord Injury in Mice
by: Yan Li, et al.
Published: (2024-02-01)

A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals
by: Jonas Brorson Jensen, et al.
Published: (2022-10-01)

Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model
by: Ibuki Arizono, et al.
Published: (2023-08-01)

Improving Mitochondrial Function in Skeletal Muscle Contributes to the Amelioration of Insulin Resistance by Nicotinamide Riboside
by: Qiuyan Li, et al.
Published: (2023-06-01)

S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
by: Angela Lee, et al.
Published: (2023-11-01)

How to mitigate neurological and cardiac decompensation in Leigh syndrome: Can nicotinamide riboside be an answer?
by: Alessandro Prigione, et al.
Published: (2022-09-01)

Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
by: Xian Zhang, et al.
Published: (2021-06-01)

Intravenous Nicotinamide Riboside Administration Has a Cardioprotective Effect in Chronic Doxorubicin-Induced Cardiomyopathy
by: Ekaterina Podyacheva, et al.
Published: (2022-10-01)

Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease
by: Armin Ahmadi, et al.
Published: (2023-06-01)

Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice
by: Xue Han, et al.
Published: (2019-08-01)

Nicotinamide Riboside Improves Stemness of Human Adipose-Derived Stem Cells and Inhibits Terminal Adipocyte Differentiation
by: Somaiah Chinnapaka, et al.
Published: (2023-08-01)

The Potential Benefic Effect of Nicotinamide Riboside in Treating a Murine Model of Monoiodoacetate-Induced Knee Osteoarthritis
by: Florin-Liviu Gherghina, et al.
Published: (2023-11-01)

Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
by: Angelique Cercillieux, et al.
Published: (2022-12-01)

Aged Nicotinamide Riboside Kinase 2 Deficient Mice Present an Altered Response to Endurance Exercise Training
by: Robin Deloux, et al.
Published: (2018-09-01)

Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults
by: Kaitlin A. Freeberg, et al.
Published: (2022-05-01)

Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling
by: Jing Wu, et al.
Published: (2024-03-01)

NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
by: Haakon Berven, et al.
Published: (2023-11-01)

Nicotinamide Riboside Supplementation to Suckling Male Mice Improves Lipid and Energy Metabolism in Skeletal Muscle and Liver in Adulthood
by: Alba Serrano, et al.
Published: (2022-05-01)

Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD+ precursor nicotinamide riboside
by: Sharath Anugula, et al.
Published: (2023-06-01)

NAA1 NICOTINAMIDE RIBOSIDE SUPPLEMENTATION REDUCES AORTIC STIFFNESS AND BLOOD PRESSURE IN MIDDLE-AGED AND OLDER ADULTS
by: Christopher Martens, et al.
Published: (2017-12-01)

The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside
by: María B. Birkisdóttir, et al.
Published: (2022-10-01)

Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 Activation
by: Anna Pezzotta, et al.
Published: (2022-10-01)

Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration
by: Tanja Sonntag, et al.
Published: (2022-11-01)

Corrigendum: The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside
by: María B. Birkisdóttir, et al.
Published: (2022-11-01)

Nicotinamide Riboside, a Promising Vitamin B<sub>3</sub> Derivative for Healthy Aging and Longevity: Current Research and Perspectives
by: Andrei Biţă, et al.
Published: (2023-08-01)